Please assess the completion status of the following clinical trial:

Trial Title: RCT of Continuous Versus Intermittent Infusion of Vancomycin in Neonates

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~- Neonates in the neonatal unit with an infection requiring treatment with vancomycin as determined by the treating physician.~Exclusion Criteria:~* Infants with a corrected gestational age \< 25 weeks.~* Allergy to vancomycin or other glycopeptide antibiotic~* Vancomycin administered within the previous 72 hours~* Renal impairment~* Prior enrolment in the study~* Need for drug that is incompatible with vancomycin (if no other IV line is available)

- Gender: ALL
- Minimum Age: None
- Maximum Age: 90 Days
- Healthy Volunteers: f

Study Arms:
- Intermittent infusion of vancomycin (Type: NO_INTERVENTION): Vancomycin will be administered intravenously over 1 hour. Doses will be given from one to four times a day according to corrected gestational age.
- Continuous infusion of vancomycin (Type: ACTIVE_COMPARATOR): A loading dose of vancomycin will be given over 1 hour followed by a continuous infusion of vancomycin over a 24 hour period.

Based on this trial design, predict the completion outcome and termination type (if applicable).